RFP Financial Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,286
Closed -$350K 563
2024
Q2
$350K Sell
3,286
-98
-3% -$9.84K 0.13% 78
2024
Q1
$327K Buy
3,384
+207
+7% +$21.2K 0.13% 76
2023
Q4
$321K Hold
3,177
0.13% 77
2023
Q3
$324K Hold
3,177
0.14% 69
2023
Q2
$321K Buy
3,177
+2,400
+309% +$240K 0.13% 74
2023
Q1
$71.5K Sell
777
-2,400
-76% -$210K 0.08% 88
2022
Q4
$288K Buy
+3,177
New +$268K 0.13% 76

Other funds holding NVS

RFP Financial Group's NVS Position: Q3 2024 in Review

RFP Financial Group sold out of Novartis (NVS) in Q3 2024, closing a stake of 3,286 shares — an estimated $350K sold.

RFP Financial Group first reported a position in NVS in Q4 2022 and held it in 7 quarters. The position peaked at $350K in Q2 2024. 1,311 funds tracked by Wall St. Rank hold NVS as of Q3 2024.

  • RFP Financial Group reported no remaining Novartis position as of Q3 2024 after selling out during the quarter.
  • RFP Financial Group sold 3,286 Novartis shares in Q3 2024, an estimated $350K.
  • RFP Financial Group first reported a position in Novartis in Q4 2022 and held it in 7 quarters.
  • RFP Financial Group's Novartis position peaked at $350K in Q2 2024.
  • 1,311 funds tracked by Wall St. Rank held Novartis as of Q3 2024.

Based on RFP Financial Group's 13F filing for Q3 2024, filed 21 Oct 2024.